Skip to main content
. 2023 May 5;34(8):705–713. doi: 10.1007/s10552-023-01709-8

Table 4.

Baseline characteristics by race and ethnicity in women from the INSIGHT-BC study

N Overall White Black Asian Hispanic Other p*
440 268 62 42 27 41
Age at diagnosis, mean (SD) 59.2 (12.0) 61.3 (11.3) 59.1 (11.3) 53.9 (11.2) 58.6 (13.7) 51.8 (12.7)  < 0.001
Months between dx and study baseline, mean (SD) 3.6 (1.9) 3.7 (1.8) 3.6 (1.7) 3.2 (2.0) 3.4 (2.1) 3.5 (2.1) 0.537
Education, N (%)
  HS or less 34 (7.7) 18 (6.7) 5 (8.1) 3 (7.1) 3 (11.1) 5 (12.2) 0.624
  Vocational/Some college 131 (29.8) 79 (29.5) 17 (27.4) 10 (23.8) 11 (40.7) 14 (34.2)
  College degree or higher 274 (62.4) 171 (63.8) 40 (64.5) 29 (69.1) 12 (44.4) 22 (53.7)
  Missing 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.7) 0 (0.0)
Comorbidity, mean (SD)
  Weighted Elixhauser score (no cancer) 1.3 (1.7) 1.2 (1.5) 2.0 (2.0) 0.6 (1.0) 1.6 (2.4) 1.1 (1.9) 0.796
Stage, N (%)
  Stage 0 13 (3.0) 5 (1.9) 6 (9.7) 1 (2.4) 0 (0.0) 1 (2.4) 0.006
  Stage I 350 (79.6) 228 (85.1) 44 (71.0) 27 (64.3) 22 (81.5) 29 (70.7)
  Stage II 62 (14.1) 27 (10.1) 10 (16.1) 13 (31.0) 3 (11.1) 9 (22.0)
  Stage III 11 (2.5) 5 (1.9) 2 (3.2) 1 (2.4) 1 (3.7) 2 (4.9)
  Stage IV 4 (0.91) 3 (1.1) 0 (0.0) 0 (0.0) 1 (3.7) 0 (0.0)
HR + , N (%) 404 (91.8) 248 (92.5) 56 (90.3) 41 (97.6) 23 (85.2) 36 (87.8) 0.318
Her2 status, N (%)
  Positive 47(10.7) 27 (10.1) 9 (14.5) 4 (9.5) 4 (14.8) 3 (7.3) 0.171
  Negative 378 (85.9) 234 (87.3) 47 (75.8) 37 (88.1) 23 (85.2) 37 (90.2)
  Equivocal/Not done 15 (3.4) 7 (2.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Method of recruitment, N (%)
  Clinic 74 (16.8) 35 (13.1) 11 (17.7) 12 (28.6) 7 (25.9) 9 (22.0) 0.027
  Email 195 (44.3) 136 (50.8) 23 (37.1) 12 (28.6) 7 (25.9) 17 (41.5)
  Letter 171 (38.9) 97 (36.2) 28 (45.2) 18 (42.9) 13 (48.2) 15 (36.6)
Survey Completion, N (%)
  Epi only 206 (46.8) 107 (39.9) 37 (59.7) 23 (54.8) 19 (70.4) 20 (48.8) 0.003
  Epi + Ego 234 (53.2) 161 (60.1) 25 (40.3) 19 (45.2) 8 (29.6) 21 (51.2)

*p value, χ2